Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Appili Therapeutics Inc (APLIF)

Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 1,668
  • Shares Outstanding, K 132,366
  • Annual Sales, $ 70 K
  • Annual Income, $ -1,890 K
  • EBIT $ -4 M
  • EBITDA $ -4 M
  • 60-Month Beta -0.21
  • Price/Sales 11.12
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $-0.01 on 02/12/26
  • Next Earnings Date 06/24/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0111 +13.51%
on 03/20/26
0.0143 -11.89%
on 03/24/26
-0.0002 (-1.56%)
since 03/10/26
3-Month
0.0111 +13.51%
on 03/20/26
0.0168 -25.00%
on 02/02/26
-0.0045 (-26.32%)
since 01/05/26
52-Week
0.0089 +41.57%
on 07/01/25
0.0309 -59.22%
on 10/02/25
-0.0090 (-41.67%)
since 04/10/25

Most Recent Stories

More News
Appili Therapeutics to Exhibit at World Vaccine Congress Washington

Appili Presentation Highlights Recent Collaborations and Funding Milestones Appili Executives to Conduct In-Person Meetings and in Washington, D.C. to Identify New Funding Opportunities HALIFAX,...

APLIF : 0.0126 (-3.08%)
APLI.TO : 0.0200 (+33.33%)
Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES HALIFAX, Nova Scotia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the...

APLIF : 0.0126 (-3.08%)
APLI.TO : 0.0200 (+33.33%)
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026

  US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million NIAID Funding Award Supports VXV-01 Development Through Phase 1 LIKMEZ® (ATI-1501) Commercial...

APLIF : 0.0126 (-3.08%)
APLI.TO : 0.0200 (+33.33%)
Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES HALIFAX, Nova Scotia, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the...

APLIF : 0.0126 (-3.08%)
APLI.TO : 0.0200 (+33.33%)
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026

New NIAID Non-Dilutive Funding Award of up to US $40Million with US$90 Million in Pending Proposals Across Multiple Infectious Disease Programs LIKMEZ® (ATI-1501): Building Commercial Momentum in...

APLIF : 0.0126 (-3.08%)
APLI.TO : 0.0200 (+33.33%)
Appili Therapeutics Announces Proposed Non-Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES HALIFAX, Nova Scotia, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF)...

APLIF : 0.0126 (-3.08%)
APLI.TO : 0.0200 (+33.33%)
Appili Therapeutics to Attend BARDA Innovation Symposium 2025

HALIFAX, Nova Scotia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTC Pink: APLIF) (“Appili” or the “Company”) today announced that it will attend the Biomedical Advanced...

APLIF : 0.0126 (-3.08%)
APLI.TO : 0.0200 (+33.33%)
Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01

Awarded contract base period of US$3.6 million to fund vaccine manufacturing with additional option periods to advance development through Phase 1 trials Submitted up to US$97 million in additional...

APLIF : 0.0126 (-3.08%)
APLI.TO : 0.0200 (+33.33%)
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders

HALIFAX, Nova Scotia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “ Company ” or “ Appili ”), a biopharmaceutical company focused on drug development...

APLIF : 0.0126 (-3.08%)
APLI.TO : 0.0200 (+33.33%)
Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference

HALIFAX, Nova Scotia, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development...

APLIF : 0.0126 (-3.08%)
APLI.TO : 0.0200 (+33.33%)

Business Summary

Appili Therapeutics Inc. is a biopharmaceutical company. It acquires, develops and commercializes novel medicines for unmet needs in the infectious disease. The company's lead product consist ATI-2307, ATI-1501 and ATI-1701 which are in clinical stage. Appili Therapeutics Inc. is based in Halifax, Canada....

See More

Key Turning Points

3rd Resistance Point 0.0126
2nd Resistance Point 0.0126
1st Resistance Point 0.0126
Last Price 0.0126
1st Support Level 0.0126
2nd Support Level 0.0126
3rd Support Level 0.0126

See More

52-Week High 0.0309
Fibonacci 61.8% 0.0225
Fibonacci 50% 0.0199
Fibonacci 38.2% 0.0173
Last Price 0.0126
52-Week Low 0.0089

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.